Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.

Data 105

Data Clinical Trials Research and Development Indica 105

The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Here’s what they found.

Sleep 133

Sleep Data Tincture Research and Development 133

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 258

Clinical Trials Chronic Pain Cannabinoids Patients 258

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 284

Chronic Pain Patients Therapy Data 284

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

Veriheal

MAY 26, 2022

With new and improved products popping up left and right, legalization initiatives taking off all over the globe, and harmful “stoner” stigmas quickly dissipating, it’s clear that cannabis has entered a new era. The days of “reefer madness” are long over, replaced by a growing acknowledgment of the cannabis plant’s therapeutic abilities.

Advocacy 96

Advocacy Patients Clinical Trials Education 96

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52

Data Treatment Patients Chronic Pain 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 105

Consumption Patients Research and Development Data 105

Cannabis Law Report

NOVEMBER 2, 2022

Cannabis Health Website reports New survey data reveals the myriad of issues facing UK patients, four years on from the legalisation of medical cannabis. Data collected from a recent survey paints a mixed picture of the experience of medical cannabis patients in the UK.

Patients 52

Patients Advocacy Data Collective 52

Cannabis Law Report

JULY 2, 2022

reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties. Can a Company Be Liable for an Accidental Data Breach?

Data 52

Data Access Topical Cannabis 52

Cannabis Law Report

DECEMBER 13, 2022

The number of medical cannabis patients in Europe grew by almost 100,000 over the last year, according to new data, but access remains out of reach for many.

Patients 52

Patients Data Access Legalization 52

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 348

Chronic Pain Clinical Trials Data Patients 348

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

NORML

FEBRUARY 28, 2020

Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. The annual revenues related to medical cannabis now total more than the total revenues generated by the sales of blueberries, maple syrup, apples, herring, and oysters combined.

Data 206

Data Patients Retail Programs 206

Veriheal

DECEMBER 14, 2021

In accordance with this, a new study found that states with legal cannabis markets have been less likely to experience incidences of EVALI, suggesting that properly regulated vape pens are not the problem. An Analysis of Nationwide EVALI Data. ” The study also discovered impacts from other variances in policies across states.

Data 97

Data Vaping Legalization Consumption 97

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

JANUARY 20, 2023

When Oregon voters passed Measure 109 in 2020, to create a legal framework for access to psilocybin services, the ballot initiative explicitly prevented the government from collecting that sensitive personal information without consent. […]

Data 52

Data Patients Legislation Collective 52

CannaMD

MARCH 4, 2020

Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. Patients can learn more by visiting ReleafApp.com. Patients can learn more by visiting ReleafApp.com.

Patients 79

Patients Data Collective Treatment 79

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Parkinson’s disease and cannabis. Interest among patients is high, but knowledge is limited.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Today, databases, predictive analytics, artificial intelligence , and machine learning are having widespread effects on cannabis businesses, investors, regulators, and consumers. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

SpeedWeed

AUGUST 31, 2021

Missouri did not launch medical cannabis sales until Oct. 16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec.

Programs 72

Programs Patients Dispensary Cultivation 72

Cannabis Law Report

FEBRUARY 10, 2023

The case, which was […]

Data 52

Data Access Patients Cannabis 52

NORML

APRIL 27, 2020

The Coalition letter focuses on the need for small business access to the SBA relief funds as an avenue to protect the progress that has been made by minority entrepreneurs in the emerging legal cannabis marketplaces. These services are especially crucial for vulnerable medical marijuana patients.

Business 317

Business Access Policy Programs 317

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 212

Retail Sleep History Medicine 212

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis to treat ankylosing spondylitis and psoriatic arthritis among many other autoimmune conditions, mental health and the effects of chronic inflammation. I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. For most Canadian patients, including myself, this means 24.3%

Access 45

Access Patients Marijuana Medicine 45

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 247

Chronic Pain Therapy Patients Topical 247

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. Some of the outcomes we’re interested in looking at, is what kind of cannabis are they using?

Medicine 140

Medicine Research and Development Data Collective 140

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 243

Cannabinoids Data Safety Patients 243

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. Medicinal cannabis products have been available since 2018. million patients currently accessing cannabis through the illicit market.

Access 52

Access CBD Research and Development Medicine 52

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 96

Medicine Treatment Patients Data 96

SpeedWeed

APRIL 6, 2021

The use of cannabis by patients enrolled in a methadone maintenance treatment program is associated with fewer nonfatal opioid overdoses, according to the results of a recently published study. Patients were asked to complete a one-time survey, which included questions about their cannabis use over the past month.

Patients 52

Patients Advocacy Treatment Data 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Veriheal

DECEMBER 14, 2023

There is a persistent and common belief throughout society that using cannabis over an extended period of time (or, in some cases, even once) can lead to a decline in mental abilities and function. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120